^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Vulvar Cancer
    Regimen:
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    04/26/2021
    Excerpt:
    Vulvar cancer (Squamous cell carcinoma): Advanced or recurrent/metastatic disease…Other recommended regimens…Cisplatin/gemcitabine (category 2B)